Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Resminostat

EU orphan designation number: EU/3/11/930   
Active ingredient: Resminostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: 4SC AG
Fraunhoferstr.22,82152 Planegg-Martinsried, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Orphan designation EMA/OD/083/11 (2011)9415 of 09/12/2011
31/03/2017 Change of name and/or address of sponsor